358 filings
10-Q
2024 Q1
VRDN
Viridian Therapeutics Inc
Quarterly report
8 May 24
7:51am
8-K
VRDN
Viridian Therapeutics Inc
8 May 24
Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
7:09am
ARS
2023 FY
VRDN
Viridian Therapeutics Inc
26 Apr 24
Annual report to shareholders
8:34am
DEFA14A
VRDN
Viridian Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
8:32am
DEF 14A
VRDN
Viridian Therapeutics Inc
Definitive proxy
26 Apr 24
8:30am
8-K
syrpzxsdc uad4b
16 Apr 24
Entry into a Material Definitive Agreement
4:06pm
S-8
4wy6if2
28 Feb 24
Registration of securities for employees
4:10pm
8-K
2x8pf1ri
27 Feb 24
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
4:07pm
8-K
9xs9yh65 y6
19 Jan 24
Entry into a Material Definitive Agreement
5:22pm
424B5
y746rfjz13e2h0u
19 Jan 24
Prospectus supplement for primary offering
4:32pm
424B5
silsm5jw246mjzn7wlt
17 Jan 24
Prospectus supplement for primary offering
4:04pm
8-K
rkhtgrjry 0obbczl
8 Jan 24
Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
8:08am
8-K
d9fxg26 wvnw
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:15am
S-3ASR
wcsu7c7wpc b4t9py
30 Nov 23
Automatic shelf registration
4:05pm
8-K
w2q luiil9cm
13 Nov 23
Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
8-K
x3wnsi4
2 Nov 23
Departure of Directors or Certain Officers
4:31pm
8-K
ljtq5ltb
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
8-K
32vgzaiy2vpo1emww9
25 Sep 23
Departure of Directors or Certain Officers
8:00am